Clinical Trial Update: A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating niraparib as maintenance therapy for advanced ovarian cancer after response to frontline platinum-based chemotherapy; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Zejula (Niraparib)

Snippet

Sponsor: Tesaro, Inc. | Conditions: Ovarian Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-06-11